Page last updated: 2024-09-03

gyki 53655 and Abdominal Migraine

gyki 53655 has been researched along with Abdominal Migraine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alt, A; Bleakman, D; Calligaro, DO; Clemens-Smith, A; Cohen, M; Dieckman, DK; Filla, SA; Gates, M; Ho, KH; Jarvie, K; Johnson, B; Johnson, KW; Katofiasc, M; Mattiuz, EL; Ogden, AM; Ornstein, PL; Phebus, LA; Rizkalla, G; Salhoff, C; Schenck, K; Schoepp, D; Stratford, RE; Weiss, B; Wright, RA1

Other Studies

1 other study(ies) available for gyki 53655 and Abdominal Migraine

ArticleYear
Pharmacological characterization of the competitive GLUK5 receptor antagonist decahydroisoquinoline LY466195 in vitro and in vivo.
    The Journal of pharmacology and experimental therapeutics, 2006, Volume: 318, Issue:2

    Topics: Animals; Benzodiazepines; Binding, Competitive; Blood Proteins; Calcium; Electrophysiology; Excitatory Amino Acid Antagonists; Humans; In Vitro Techniques; Isoquinolines; Ligands; Male; Migraine Disorders; Motor Activity; Muscle Contraction; Muscle, Smooth, Vascular; Neurons; Phencyclidine; Proto-Oncogene Proteins c-fos; Rabbits; Rats; Receptors, AMPA; Receptors, Kainic Acid; Saphenous Vein; Transfection

2006